Investegate |Oxford BioDynamics Announcements | Oxford BioDynamics: New UK facilities to support expanded strategy
at Oxford Business Park, supporting expanded strategy Oxford, UK - 9 April 2021 - Oxford BioDynamics Plc (AIM: OBD, the Company), a biotechnology company developing precision medicine tests for personalized healthcare based on the EpiSwitch® 3D genomics platform, has signed a lease agreement for new laboratory and office space at Oxford Business Park , to significantly expand its UK facilities. The 24,000 sq ft premises will house the Company's growing UK infrastructure, as it continues the execution of its expanded strategic focus , announ...
Source: investegate.co.uk